GRDN vs LTC: How Guardian Pharmacy Services and LTC Properties Compare (2026)
Last updated August 2026
Short answer
GRDN is the larger of the two ($2.81B market cap): the incumbent the market prices for continued execution (32.70x forward earnings). LTC is the smaller challenger ($2.06B), cheaper on forward earnings (24.46x): more room to run, but more to prove. The real question is which set of drivers you believe, and whether owning one (or both) leaves you over-concentrated.
GRDN vs LTC: the tie-breaker metrics
Same yardstick, side by side (as of August 2026). Valuation lined up like this is most meaningful for two names in the same corner of the market, which these are. Figures are approximate; verify before investing.
| Metric | GRDN | LTC | What it tells you |
|---|---|---|---|
| Market cap | $2.81B | $2.06B | Size. The larger name is the incumbent; the smaller has more room to grow and more to prove. |
| Forward P/E | 32.70 | 24.46 | Valuation on next year's expected earnings, the same yardstick for both. Lower is cheaper for that growth; higher means the market is paying up. |
| Trailing P/E | 54.16 | 15.78 | Valuation on the last 12 months. A big drop from trailing to forward means the market expects earnings to jump, so more growth is already in the price. |
| Price vs 52-week range | 95% of range | 71% of range | Where today's price sits between the 52-week low and high. Near the high is momentum with less margin of safety; near the low is out of favor or a discount, depending on why. |
| Price / book | 12.73 | 2.05 | How much you pay over book value. Very high can signal an asset-light, high-return business or a rich price. |
Reading it: LTC is the cheaper of the two on forward earnings, but cheaper is not the same as better. Pair the valuation with growth (how far the forward P/E sits below the trailing P/E) and risk (beta) before you decide.
Before you buy: how GRDN and LTC affect your concentration
The metrics above tell you which is the marginally better business. The bigger risk for most people is not picking the slightly worse stock, it is over-concentrating. GRDN and LTC share themes, so owning both, or adding either to what you already hold, can quietly push a large share of your portfolio into one bet.
This is the part a generic comparison page cannot answer, because it depends on what you own. Connect your brokerage and Walnut shows your real, combined GRDN and LTC exposure, flags overlap with your existing positions, and tells you if adding one would tip you past a concentration you are comfortable with, read-only by default, with your login staying at your broker. Walnut is not an investment adviser.
What does Guardian Pharmacy Services (GRDN) do?
Guardian Pharmacy Services runs closed-door pharmacies, not storefronts. Its pharmacies do not serve walk-in customers: they serve facilities, handling routine cycle fills, compliance packaging sorted by resident and dose time, urgent and after-hours deliveries, integration with facility electronic medication administration records, and the reimbursement work of billing Medicare Part D, Medicaid and commercial payors. The deliberate difference versus the incumbents is the customer type. More than two thirds of revenue comes from assisted living facilities and behavioral health facilities rather than the skilled nursing homes where Omnicare and PharMerica hold most of the share. Guardian also operates unusually for a roll-up: acquired and greenfield pharmacies are run by a local president who typically keeps a minority equity stake in that pharmacy, while corporate supplies purchasing scale, technology, billing and back office. As of March 31, 2026 that network was ~61 licensed pharmacies, ~54 of them full service, across 38 states. The company was founded in 2003 and listed on the NYSE in September 2024.
What does LTC Properties (LTC) do?
LTC Properties is a real estate investment trust that owns and finances seniors housing and skilled nursing facilities, holding roughly 180 investments across about 27 states with a couple dozen operating partners. Historically it collected rent through triple-net leases (where operators pay taxes, insurance, and maintenance) and earned interest on mortgage loans, giving it a landlord-style, predictable income stream. It has long been known to income investors as a monthly dividend payer.
GRDN vs LTC: how do they differ?
Both fit overlapping themes, but they are not interchangeable. The useful comparison is which set of drivers and risks you want exposure to.
- GRDN drivers: Resident growth is running well ahead of reported revenue; A repeatable acquisition and greenfield flywheel.
- LTC drivers: SHOP / RIDEA transition to operated senior housing; Aging-population demand tailwind.
Which fits which kind of investor
A faster-growing, richer-valued name usually swings harder, so it suits a longer horizon and a higher tolerance for volatility; a steadier, more cash-generative business suits a more conservative or income-minded investor. The honest test is which set of risks you could hold through a drawdown: Reimbursement is the structural risk and it is not hypothetical: the IRA Part D redesign already cut prices roughly 60% on the affected portion of Guardian's branded book, and further legislative or CMS changes, plus ongoing PBM rate pressure, could compress economics again with little notice. For LTC, the SHOP model removes the buffer of triple-net leases and exposes LTC directly to operating costs, labor, and occupancy swings, so a downturn at a few communities can hit earnings faster than under a lease structure.
GRDN or LTC: which should you pick?
Growth-minded investors who believe the theme has years to run tend to accept the richer multiple for more upside; value-minded investors lean toward the cheaper forward earnings and steadier profile. Pick GRDN if you believe its drivers more; LTC if you believe its. Many investors hold both, but since they share themes, that is a concentrated bet, not diversification. Decide deliberately and check overlap. For the full detail, see the GRDN and LTC guides.
GRDN vs LTC: the full fundamentals
GRDN. The reported growth rate understates the business right now: residents and scripts both grew high single digits while revenue grew ~2%, because IRA pricing removed drug dollars that carried almost no margin. That is why gross margin widened from ~20.2% in fiscal 2025 to ~21.6% on a trailing basis, and why adjusted EBITDA guidance has been raised three times in 2026 while revenue guidance moved only once. The multiple embeds continued execution: at ~43 times trailing earnings with ~$79.8 million of trailing free cash flow, the shares are priced closer to a compounding services roll-up than to a drug distributor, and the stock has already run from a 52-week low near ~$19.30 to roughly ~$44.65.
LTC. At a share price around $37, LTC trades at roughly 14 times forward Core FFO, a modest multiple relative to larger healthcare REITs. Q1 2026 total revenue nearly doubled year over year to about $95 million as SHOP acquisitions were absorbed, and Nareit FFO per share rose to about $0.72. For a REIT, FFO and FAD per share and dividend coverage are more meaningful than plain EPS, and management reaffirmed its full-year guidance.
Headline figures (approximate, August 2026): GRDN shows revenue (ttm) ~$1.46 billion, up ~10.3% year over year, q2 2026 revenue ~$351.8 million, up ~2% (beat the ~$340 million consensus), q2 2026 adjusted ebitda ~$29.7 million, up ~19% from ~$25.0 million, net income / eps (ttm) ~$65.9 million, ~$1.03 diluted EPS (Q2 adjusted EPS ~$0.29 vs ~$0.26 consensus); LTC shows revenue (q1 2026) ~$95M, nareit ffo (q1 2026) ~$0.72/share, core ffo guidance (fy2026) ~$2.75 to $2.79/share, dividend (annualized) ~$2.28/share.
The bottom line: GRDN vs LTC
GRDN and LTC are related but distinct: same themes, different businesses and risks. Neither wins in the abstract; the right pick is whichever thesis you actually believe, sized so you are not over-concentrated in one theme. Walnut can show your combined GRDN and LTC exposure against your real portfolio. It is not an investment adviser.
Wondering how GRDN or LTC fits the portfolio you already own? Walnut is an AI investing app that connects your brokerage read-only and answers questions like that about your actual holdings: overlap, concentration, and how each position tracks the S&P 500. Compare the best AI portfolio analyzers or see the best AI investing apps in 2026.
Investing in Guardian Pharmacy Services with AI
Connect the broker you already use and ask Walnut's AI how GRDN fits what you actually hold: whether you own it already through a fund, what it would do to your concentration, and how it has tracked the S&P 500. Read-only by default, and you approve anything before it reaches your broker.
FAQ
What is the difference between GRDN and LTC?
+
Guardian Pharmacy Services runs closed-door pharmacies, not storefronts. LTC Properties is a real estate investment trust that owns and finances seniors housing and skilled nursing facilities, holding roughly 180 investments across about 27 states with a couple dozen operating partners. They show up together because they share investment themes, but they are different businesses, so the better fit depends on which thesis you are expressing.
Is GRDN or LTC the better stock?
+
Neither is universally better. GRDN is the larger incumbent; LTC is the smaller challenger and looks cheaper on forward earnings. Walnut is informational, not investment advice. Compare what each does, the tie-breaker metrics above, and the risks, then decide which fits your thesis and what you already own.
Which is cheaper, GRDN or LTC?
+
On forward P/E (as of August 2026), GRDN trades at 32.70x and LTC at 24.46x, so LTC is the cheaper of the two on next year's expected earnings. A lower multiple is not automatically the better buy: a richer valuation can be justified by faster growth, and a lower one can reflect real risk. Weigh the multiple against how fast each business is compounding.
Should you own both GRDN and LTC?
+
Because they share themes, owning both concentrates you in that theme. That can be intentional (a focused bet) or accidental (less diversification than it looks). Walnut can show your combined exposure across both, and whether adding either over-concentrates you, before you buy.
What are the risks of GRDN vs LTC?
+
GRDN: Reimbursement is the structural risk and it is not hypothetical: the IRA Part D redesign already cut prices roughly 60% on the affected portion of Guardian's branded book, and further legislative or CMS changes, plus ongoing PBM rate pressure, could compress economics again with little notice. Growth depends on continued acquisitions, which carries integration risk, goodwill accumulation and the possibility that multiples paid for independent pharmacies rise as the strategy becomes better known. Demand is tied to assisted living and behavioral health occupancy and to facility operators' own financial health, so a downturn in senior housing census would show up directly in resident counts. Operationally, the business runs on licensed pharmacists and technicians in tight labor markets and is regulated by the DEA, state boards of pharmacy and federal anti-kickback and fraud statutes, any of which can produce fines or license actions. Finally, the equity itself carries structural features worth understanding: a dual-class structure concentrates voting control, the public float is roughly half of shares outstanding with a shelf registration on file that permits additional Class A supply, valuation near ~43 times trailing earnings leaves little cushion for a guidance miss, and the second quarter's net income included an ~$8.5 million payor-dispute settlement that will not repeat. LTC: The SHOP model removes the buffer of triple-net leases and exposes LTC directly to operating costs, labor, and occupancy swings, so a downturn at a few communities can hit earnings faster than under a lease structure. Concentration among a limited set of operating partners means one troubled operator can be material. As a REIT, the stock is interest-rate sensitive: higher-for-longer rates raise financing costs and pressure valuation multiples. Skilled nursing exposure carries reimbursement and regulatory risk tied to Medicare and Medicaid policy. Finally, the transition itself is unproven at this scale for LTC, and if SHOP margins or dispositions disappoint, both FFO growth and the dividend cushion could tighten.
Walnut is informational, not investment advice. This page is descriptive and not a recommendation to buy or sell GRDN or LTC; figures are approximate and dated (as of August 2026). Verify current data before investing.